文献速递主动脉外科

胸主动脉腔内修复术后二次主动脉干预对长期生存的影响

Impact of Secondary Aortic Interventions After Thoracic Endovascular Aortic Repair on Long-Term Survival.
PubMed 文献 · Ann Thorac Surg · 2019-11-27

单中心回顾性分析2004至2018年1037例TEVAR患者,155例(14.9%)接受212次二次主动脉干预(SAI),中位时间5个月。

要点

  • TEVAR后SAI并不少见,慢性夹层患者发生率最高(26.5%)。
  • SAI最常见指征为内漏(44.8%),其次为疾病进展或远端主动脉手术(23.1%)。
  • 发生SAI者远期生存更差,10年生存率仅33.5%。

核心结论

  • TEVAR后二次主动脉干预并不少见,尤其在慢性夹层患者中。
  • 初次住院存活后接受SAI的患者长期生存更差。
  • SAI发生率随指征不同,提示需按病理选择患者、制定监测策略并改进器械设计。

研究设计与样本

  • 单中心回顾性综述,纳入2004至2018年所有TEVAR及SAI病例。
  • 共1037例患者,平均年龄65.4±15.1岁。
  • 采用Kaplan-Meier和多因素logistic回归估计免于SAI生存率和生存率,并识别SAI预测因素。

主要发现

  • 155例(14.9%)接受212次SAI,中位时间5个月(四分位距1.5至18),37例(3.6%)需多于一次SAI。
  • SAI最常见指征为内漏(44.8%)、疾病进展或远端主动脉手术(23.1%)、持续性假腔血流(9.9%)。

临床怎么用

  • 对TEVAR术后患者,尤其慢性夹层病理,应加强监测以早期发现需二次干预的情况。
  • 发生SAI提示远期生存劣化,需强化随访与综合管理。
  • 患者选择与器械设计应针对夹层相关指征的局限性进行优化。

局限性

  • 单中心回顾性研究,可能存在选择偏倚与资料不完整。
  • SAI组样本量较小(155例),远期生存估计置信区间较宽。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The indications for and technology surrounding thoracic endovascular aortic repair (TEVAR) have undergone significant evolution with increasing adoption. The purpose of this report is to evaluate pathology-specific incidence, timing, and types of secondary aortic intervention (SAI) after TEVAR and their impact on survival. METHODS: A single-center retrospective review was made of all TEVAR and SAI performed from 2004 to 2018. Kaplan-Meier and multivariable logistic regression were used to estimate freedom from SAI and survival, and to identify SAI predictors. RESULTS: Of 1037 patients (mean age 65.4 ± 15.1 years), 155 (14.9%) underwent 212 SAIs (median 5 months; interquartile range, 1.5 to 18) with 37 (3.6%) requiring more than one SAI. The primary aortic pathology at index TEVAR significantly (P = .0001) affected the incidence of SAI: chronic dissection, 26.5%; postsurgical anastomotic pseudoaneurysm, 19.4%; degenerative aneurysm, 15.3%; and acute dissection, 11.2%. The most common indications for SAI were endoleaks (44.8%), disease progression or remote aortic procedure (23.1%), and persistent false lumen flow (9.9%). After exclusion of 30-day mortality events, patients who did not undergo a SAI had better survival compared with patients having SAI: no SAI 1 year 88.8% ± 1.1%, 5 years 75.2% ± 1.7%, and 10 years, 66.5% ± 2.3%; SAI 1 year 91.7% ± 2.4%, 5 years 61.9% ± 4.9%, and 10 years 33.5% ± 8.4% (log rank P = .004). CONCLUSIONS: Secondary aortic intervention after TEVAR is not uncommon, particularly among patients with chronic dissection pathology. Patients surviving their index hospitalization who undergo SAI have worse long-term survival. The varying incidence of SAI by indication identifies the need for pathology-specified patient selection, surveillance strategies after TEVAR, and better device design that addresses the limitations of TEVAR, particularly in dealing with dissection-related indications.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Alhussaini M, Arnaoutakis GJ, Scali ST, et al. Impact of Secondary Aortic Interventions After Thoracic Endovascular Aortic Repair on Long-Term Survival. Ann Thorac Surg. 2019. PMID: 31785293. doi:10.1016/j.athoracsur.2019.10.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。